Cocrystal Pharma, Inc. (NASDAQ:COCP – Get Free Report) shares rose 0.5% during mid-day trading on Friday . The stock traded as high as $1.91 and last traded at $1.87. Approximately 15,419 shares changed hands during trading, a decline of 56% from the average daily volume of 34,821 shares. The stock had previously closed at $1.86.
Wall Street Analysts Forecast Growth
Separately, HC Wainwright reiterated a “buy” rating and set a $7.00 target price on shares of Cocrystal Pharma in a research report on Wednesday, January 22nd.
Read Our Latest Analysis on COCP
Cocrystal Pharma Stock Up 0.5 %
Cocrystal Pharma Company Profile
Cocrystal Pharma, Inc, a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, norovirus, and respiratory virus infections.
Further Reading
- Five stocks we like better than Cocrystal Pharma
- With Risk Tolerance, One Size Does Not Fit All
- Symbotic Shares Down 37%—Is It Time for Bravery or Caution?
- How to Profit From Growth Investing
- High-Yield Healthcare: 3 Stocks With Strong Dividends
- 3 Healthcare Dividend Stocks to Buy
- Beyond the Bargain Bin: 3 Stocks Leading Discount Retail
Receive News & Ratings for Cocrystal Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cocrystal Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
